bf/NASDAQ:REVB_icon.jpeg

COM:REVBIOSCIENCES

Revelation Biosciences, Inc.

  • Stock

Last Close

0.75

22/11 21:00

Market Cap

2.91M

Beta: -

Volume Today

115.97K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
25.05K
-
gross profit
-25.05K
-
selling and marketing expenses
-25.05K
-
general and administrative expenses
145.49K
-
5.04M
3,361.17%
5.49M
8.96%
4.51M
17.79%
selling general and administrative expenses
3.64K
-
145.49K
3,899.23%
5.04M
3,361.17%
5.49M
8.96%
4.49M
18.25%
research and development expenses
6.91M
-
5.38M
22.23%
4.15M
22.90%
other expenses
-36.35K
-
34.96K
196.18%
cost and expenses
3.64K
-
145.49K
3,899.23%
11.95M
8,113.84%
10.86M
9.09%
8.66M
20.32%
operating expenses
3.64K
-
145.49K
3,899.23%
11.95M
8,113.84%
10.86M
9.09%
8.63M
20.55%
interest expense
-41.76K
-
-34.96K
16.28%
ebitda
-3.64K
-
-145.49K
3,897.03%
-11.93M
8,102.31%
-10.84M
9.17%
-8.63M
20.37%
operating income
-3.64K
-
-145.49K
3,897.03%
-11.95M
8,113.84%
-10.86M
9.09%
-8.66M
20.32%
depreciation and amortization
16.78K
-
25.05K
49.26%
25.05K
0.00%
total other income expenses net
2
-
9.08K
454,100%
-36.35K
500.18%
34.96K
196.18%
8.54M
24,316.24%
income before tax
-3.64K
-
-136.41K
3,649.53%
-11.99M
8,687.49%
-10.83M
9.65%
-120.25K
98.89%
income tax expense
-34.96K
-
1
100.00%
net income
-3.64K
-
-136.41K
3,649.53%
-11.99M
8,687.49%
-10.79M
9.95%
-120.25K
98.89%
weighted average shs out
4.37M
-
369.83K
91.54%
539.04K
45.75%
228.64K
57.58%
weighted average shs out dil
4.37M
-
369.83K
91.54%
539.04K
45.75%
228.64K
57.58%
eps
-0.42
-
-0.03
92.57%
-32.41
103,778.21%
-20.03
38.20%
-0.53
97.35%
epsdiluted
-0.42
-
-0.03
92.57%
-32.41
103,778.21%
-20.03
38.20%
-0.53
97.35%

All numbers in (except ratios and percentages)